Sarcoidosis Associated with Oxaliplatin-Based Chemotherapy for Colorectal Cancer

被引：10
|
作者：
Choi, Ji Hoon [1 ]
Shin, Jung A. [1 ]
Park, Hye Kyeong [1 ]
Kim, Su Young [2 ]
Jung, Hoon [1 ]
Lee, Sung-Soon [1 ]
Lee, Hye Ran [1 ]
Koo, Hyeon-Kyoung [1 ]
机构：
[1] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Goyang Si 2240, Gyeonggi Do, South Korea
[2] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Radiol, Goyang Si 2240, Gyeonggi Do, South Korea
来源：
CASE REPORTS IN ONCOLOGICAL MEDICINE | 2014年 / 2014卷
关键词：
D O I：
10.1155/2014/203027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Acute lung injury occasionally occurs after chemotherapy, but pulmonary toxicities by oxaliplatin-based chemotherapy have rarely been identified. A 76-year-old female with rectosigmoid colon cancer presented with ongoing dyspnea after the eighth cycle of standard chemotherapy (5-fluorouracil, sodium folinic acid, and oxaliplatin: FOLFOX). Nodular consolidation progressed despite antibiotics and BAL fluid analysis was compatible with the diagnosis of sarcoidosis. Corticosteroid therapy rapidly improved the symptoms and radiographic findings. We report this first case of secondary sarcoidosis related to FOLFOX therapy with review of references.
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Safety and Effectiveness of Oxaliplatin-Based Chemotherapy Regimens in Adults 75 Years and Older With Colorectal Cancer
    McCleary, Nadine Jackson
    Odejide, Oreofe
    Szymonifka, Jackie
    Ryan, David
    Hezel, Aram
    Meyerhardt, Jeffrey A.
    CLINICAL COLORECTAL CANCER, 2013, 12 (01) : 62 - 69
  • [32] Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer
    Sundar, Raghav
    Miranda, Susana
    Rodrigues, Daniel Nava
    Chenard-Poirier, Maxime
    Dolling, David
    Clarke, Matthew
    Figueiredo, Ines
    Bertan, Claudia
    Yuan, Wei
    Ferreira, Ana
    Chistova, Rossitza
    Boysen, Gunther
    Perez, Desamparados Roda
    Tunariu, Nina
    Mateo, Joaquin
    Wotherspoon, Andrew
    Chau, Ian
    Cunningham, David
    Valeri, Nicola
    Carreira, Suzanne
    de Bono, Johann
    CLINICAL COLORECTAL CANCER, 2018, 17 (04) : 280 - 284
  • [33] Peripheral neuropathy - complication after oxaliplatin-based chemotherapy for colorectal cancer. Preliminary report
    Banach, Marta
    Zygulska, Aneta L.
    Krzemieniecki, Krzysztof
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2015, 17 (04): : 262 - 266
  • [34] Neoadjuvant oxaliplatin-based chemotherapy for liver metastases from colorectal cancer. An Italian survey
    Zaniboni, A
    Torri, V
    Tinazzi, A
    Codignola, C
    Faggiuolo, R
    Sperti, E
    TUMORI, 2005, 91 (05) : 383 - 387
  • [35] Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
    Cashin, Peter H.
    Ghanipour, Lana
    Enblad, Malin
    Morris, David L.
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (05) : 549 - 558
  • [36] PKM2 as a biomarker for sensitivity to oxaliplatin-based chemotherapy in metastatic colorectal cancer (mCRC).
    Papadaki, C.
    Saridaki, Z.
    Tzardi, M.
    Sfakianaki, M.
    Sfakiotaki, G.
    Trypaki, M.
    Messaritakis, I.
    Mavroudis, D.
    Georgoulias, V.
    Sougklakos, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [37] Outcomes in patients (pts) with colorectal cancer (CRC) treated with oxaliplatin-based chemotherapy (OC) following prior oxaliplatin exposure
    Bhadkamkar, Nishin Anil
    Sahin, Ibrahim Halil
    Shen, Yehua
    Hassabo, Hesham Mohamed
    Kee, Bryan K.
    Hassan, Manal
    Garrett, Chris R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [38] Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
    Eren, Tulay
    Pasaoglu, Lale
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [39] Bevacizumab plus Oxaliplatin-Based Regimens for the Treatment of Colorectal Cancer
    Scheithauer, Werner
    Schmiegel, Wolff
    ONKOLOGIE, 2009, 32 (07): : 431 - 439
  • [40] MGMT −535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy
    Jee Hyun Park
    Nung Soo Kim
    Jae Yong Park
    Yee Soo Chae
    Jong Gwang Kim
    Sang Kyun Sohn
    Joon Ho Moon
    Byung Woog Kang
    Hun Mo Ryoo
    Sung Hwa Bae
    Gyu Seog Choi
    Soo-Han Jun
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1135 - 1142
12345